Atlas Trials

Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate

Clinical trial NCT01857531 · COMPLETED

Trial details

NCT number
NCT01857531
Sponsor
Jed E. Rose
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2013-06-01
Primary completion
2013-07-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.